{"id":58874,"date":"2026-04-21T22:12:31","date_gmt":"2026-04-21T22:12:31","guid":{"rendered":"https:\/\/www.parkinson.ca\/?post_type=clinical-trial&#038;p=58874"},"modified":"2026-04-21T22:12:32","modified_gmt":"2026-04-21T22:12:32","slug":"screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases","status":"publish","type":"clinical-trial","link":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/","title":{"rendered":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes both prospective data collection and retrospective analysis of existing imaging data.\u00a0<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Location: University of Saskatchewan, Saskatoon SK<\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2026\/04\/Poster_RM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Study flyer<\/a><\/div>\n<\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"featured_media":58877,"template":"","class_list":["post-58874","clinical-trial","type-clinical-trial","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"google-site-verification\" content=\"2AhivUiST2eKQcfei6JBM5Zbf8YQRvHy0kRBp9sDLWo\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Parkinson Canada -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-04-21T22:12:31+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-04-21T22:12:32+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/parkinsoncanada\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@parkinsoncanada\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/#listItem\",\"name\":\"Clinical Trials\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/#listItem\",\"position\":2,\"name\":\"Clinical Trials\",\"item\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#listItem\",\"name\":\"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#listItem\",\"position\":3,\"name\":\"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/#listItem\",\"name\":\"Clinical Trials\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#organization\",\"name\":\"Parkinson Canada\",\"description\":\"Parkinson Canada empowers people living with Parkinson\\u2019s and their care partners to thrive. Through advocacy, education, and support, we work to improve access to care, advance research, and build a stronger Parkinson\\u2019s community across Canada. Join us in making a difference.\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"email\":\"info@parkinson.ca\",\"telephone\":\"+18005653000\",\"foundingDate\":\"1965-04-11\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/parkinson.ca\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Parkinson-Canada-logo-23-RGB.jpg\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/parkinsoncanada\",\"https:\\\/\\\/twitter.com\\\/parkinsoncanada\",\"https:\\\/\\\/instagram.com\\\/parkinsoncanada\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm_sAjRqhAaiutx2B9dOqng\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/parkinson-canada\"]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#webpage\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/\",\"name\":\"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada\",\"description\":\"Our project focuses on early detection of Alzheimer\\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\\u2019s disease and 100 healthy controls and includes\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/1200x628-5.png\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#mainImage\",\"width\":1200,\"height\":628,\"caption\":\"University of Saskatchewan logo\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/clinical-trial\\\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\\\/#mainImage\"},\"datePublished\":\"2026-04-21T22:12:31+00:00\",\"dateModified\":\"2026-04-21T22:12:32+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"name\":\"Parkinson Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada","description":"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes","canonical_url":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"2AhivUiST2eKQcfei6JBM5Zbf8YQRvHy0kRBp9sDLWo","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/www.parkinson.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/#listItem","name":"Clinical Trials"}},{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/#listItem","position":2,"name":"Clinical Trials","item":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#listItem","name":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#listItem","position":3,"name":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases","previousItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/#listItem","name":"Clinical Trials"}}]},{"@type":"Organization","@id":"https:\/\/www.parkinson.ca\/fr\/#organization","name":"Parkinson Canada","description":"Parkinson Canada empowers people living with Parkinson\u2019s and their care partners to thrive. Through advocacy, education, and support, we work to improve access to care, advance research, and build a stronger Parkinson\u2019s community across Canada. Join us in making a difference.","url":"https:\/\/www.parkinson.ca\/fr\/","email":"info@parkinson.ca","telephone":"+18005653000","foundingDate":"1965-04-11","numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"logo":{"@type":"ImageObject","url":"https:\/\/parkinson.ca\/wp-content\/uploads\/2025\/01\/Parkinson-Canada-logo-23-RGB.jpg","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#organizationLogo"},"image":{"@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#organizationLogo"},"sameAs":["https:\/\/facebook.com\/parkinsoncanada","https:\/\/twitter.com\/parkinsoncanada","https:\/\/instagram.com\/parkinsoncanada","https:\/\/www.youtube.com\/channel\/UCm_sAjRqhAaiutx2B9dOqng","https:\/\/www.linkedin.com\/company\/parkinson-canada"]},{"@type":"WebPage","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#webpage","url":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/","name":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada","description":"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/www.parkinson.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2026\/04\/1200x628-5.png","@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#mainImage","width":1200,"height":628,"caption":"University of Saskatchewan logo"},"primaryImageOfPage":{"@id":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/#mainImage"},"datePublished":"2026-04-21T22:12:31+00:00","dateModified":"2026-04-21T22:12:32+00:00"},{"@type":"WebSite","@id":"https:\/\/www.parkinson.ca\/fr\/#website","url":"https:\/\/www.parkinson.ca\/fr\/","name":"Parkinson Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/www.parkinson.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"Parkinson Canada -","og:type":"article","og:title":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada","og:description":"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes","og:url":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/","og:image":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png","og:image:secure_url":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png","og:image:width":1000,"og:image:height":600,"article:published_time":"2026-04-21T22:12:31+00:00","article:modified_time":"2026-04-21T22:12:32+00:00","article:publisher":"https:\/\/facebook.com\/parkinsoncanada","twitter:card":"summary_large_image","twitter:site":"@parkinsoncanada","twitter:title":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases - Parkinson Canada","twitter:description":"Our project focuses on early detection of Alzheimer\u2019s disease using non-invasive retinal imaging techniques (OCT and OCT-angiography), combined with machine learning analysis. By analyzing retinal structural changes, we aim to identify early biomarkers of Alzheimer\u2019s before clinical symptoms appear. The study involves recruiting approximately 100 individuals with Alzheimer\u2019s disease and 100 healthy controls and includes","twitter:image":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png"},"aioseo_meta_data":{"post_id":"58874","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-04-21 22:10:51","updated":"2026-04-21 23:09:16","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.parkinson.ca\/fr\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/\" title=\"Clinical Trials\">Clinical Trials<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tScreening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.parkinson.ca\/fr\/"},{"label":"Clinical Trials","link":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/"},{"label":"Screening eyes of people in Saskatchewan with non-invasive imaging technologies and artificial intelligence for early detection of neurodegenerative diseases","link":"https:\/\/www.parkinson.ca\/fr\/clinical-trial\/screening-eyes-of-people-in-saskatchewan-with-non-invasive-imaging-technologies-and-artificial-intelligence-for-early-detection-of-neurodegenerative-diseases\/"}],"_links":{"self":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/clinical-trial\/58874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/clinical-trial"}],"about":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/types\/clinical-trial"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media\/58877"}],"wp:attachment":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media?parent=58874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}